Analytical strategies for assessing comparability of biosimilars

作者: Robert J. Falconer , Dianne Jackson-Matthews , Stephen M. Mahler

DOI: 10.1002/JCTB.2629

关键词:

摘要: Biosimilar products are required by regulatory authorities to have appropriate and comparable quality, safety efficacy with a reference biologic product. The analytical techniques that available manufacturers of biosimilar medicines well advanced present range options characterize the compare them relevant marketed This variety methods can be used investigate attributes candidate biologic, ensures orthogonal deployed single attribute, facilitating rigorous structural characterization physicochemical evaluation. These methodologies not only enable evidence for bio-comparability amassed but also developer biosimilars incorporate risk mitigation into development strategy. review discusses support comparability testing, handling material strategic aspects commercializing or follow-on biological medicinal products.

参考文章(58)
Thomas A. Morton, David G. Myszka, Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods in Enzymology. ,vol. 295, pp. 268- 294 ,(1998) , 10.1016/S0076-6879(98)95044-3
V.V. Novokhatny, K.C. Ingham, L.V. Medved, Domain structure and domain-domain interactions of recombinant tissue plasminogen activator. Journal of Biological Chemistry. ,vol. 266, pp. 12994- 13002 ,(1991) , 10.1016/S0021-9258(18)98794-6
Vladimir Hlady, Jos Buijs, Herbert P. Jennissen, Methods for Studying Protein Adsorption Methods in Enzymology. ,vol. 309, pp. 402- 429 ,(1999) , 10.1016/S0076-6879(99)09028-X
Matthias Wilm, Andrej Shevchenko, Tony Houthaeve, Stephen Breit, Lothar Schweigerer, Theodore Fotsis, Matthias Mann, None, Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry Nature. ,vol. 379, pp. 466- 469 ,(1996) , 10.1038/379466A0
Gary Walsh, Biopharmaceutical benchmarks 2010 Nature Biotechnology. ,vol. 28, pp. 917- 924 ,(2010) , 10.1038/NBT0910-917
Shunmugaperumal Tamilvanan, Natarajan Livingston Raja, Biswanath Sa, Sanat Kumar Basu, Clinical concerns of immunogenicity produced at cellular levels by biopharmaceuticals following their parenteral administration into human body Journal of Drug Targeting. ,vol. 18, pp. 489- 498 ,(2010) , 10.3109/10611861003649746
Katia Boven, Scott Stryker, John Knight, Adrian Thomas, Marc van Regenmortel, David M Kemeny, David Power, Jerome Rossert, Nicole Casadevall, None, The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney International. ,vol. 67, pp. 2346- 2353 ,(2005) , 10.1111/J.1523-1755.2005.00340.X
Thomas M. Dillon, Pavel V. Bondarenko, Douglas S. Rehder, Gary D. Pipes, Gerd R. Kleemann, Margaret Speed Ricci, Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. Journal of Chromatography A. ,vol. 1120, pp. 112- 120 ,(2006) , 10.1016/J.CHROMA.2006.01.016
Jurij Lah, Iztok Prislan, Blaž Kržan, Mateja Salobir, Andrej Francky, Gorazd Vesnaver, Erythropoietin unfolding: thermodynamics and its correlation with structural features Biochemistry. ,vol. 44, pp. 13883- 13892 ,(2005) , 10.1021/BI0512952